Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EBIT Growth

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 1.6723.29476.0245.5432.18

What is the latest EBIT Growth ratio of ORCHID PHARMA ?

The latest EBIT Growth ratio of ORCHID PHARMA is 1.67 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar20251.67
Mar202423.29
Mar2023476.02
Mar202245.54
Mar202132.18

How is EBIT Growth of ORCHID PHARMA Trending?

Years EBIT Growth % Change
Mar2025 1.67
-92.83
Mar2024 23.29
-95.11
Mar2023 476.02
945.28
Mar2022 45.54
41.52
Mar2021 32.18 -

Other Financial Ratios of ORCHID PHARMA


Compare EBIT Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,543.7 Cr 1.3% -7.1% -51.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

1.3%

-7.1%

-51.7%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses